A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. [electronic resource]
Producer: 20041228Description: 1059-66 p. digitalISSN:- 0884-0431
- Aged
- Alkaline Phosphatase -- blood
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Bone Resorption -- drug therapy
- Calcium -- blood
- Carrier Proteins -- antagonists & inhibitors
- Cohort Studies
- Collagen -- urine
- Collagen Type I
- Denosumab
- Female
- Humans
- Membrane Glycoproteins -- antagonists & inhibitors
- Middle Aged
- Parathyroid Hormone -- blood
- Peptides -- urine
- RANK Ligand
- Receptor Activator of Nuclear Factor-kappa B
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.